Vanguard Group »

Terns Pharmaceuticals shares owned by Vanguard Group

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 2.3M 6.81
2024-03-31 $14M 2.2M 6.56
2023-12-31 $14M 2.2M 6.49
2023-09-30 $11M 2.2M 5.03
2023-06-30 $20M 2.2M 8.75
2023-03-31 $15M 1.3M 11.84
2022-12-31 $12M 1.1M 10.18
2022-06-30 $912k 368k 2.48
2022-03-31 $1.3M 433k 2.97
2021-09-30 $4.6M 441k 10.42
2021-06-30 $5.1M 416k 12.29
2021-03-31 $13M 576k 21.98